Clinical Pharmacology and Therapeutics - Table of Contents alert Volume 95 Issue 1

TABLE OF CONTENTS Volume 95, Issue 1 (January 2013) In this issue In This Issue Editorial News & Views State of the Art Corrigendum Also new AOP Sign up for CPT: Pharmacometrics & Systems Pharmacology e-alerts Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Podcast: Population Modeling, Simulation, and Model Based Drug Development  PSPod is a new podcast series from CPT: Pharmacometrics & Systems Pharmacology In this inaugural podcast we discuss CPT:PSP Tutorials, a new series of articles serving as important educational material on the tools, methodologies, and approaches used for modeling and simulation.   In This Issue Top In This Issue Clin Pharmacol Ther 2013 95: 1; 10.1038/clpt.2013.225 Full Text Editorial Top Molecular Insights Provide the Critical Path to Disease Mitigation S A Waldman and A Terzic Clin Pharmacol Ther 2013 95: 3-7; 10.1038/clpt.2013.211 Abstract | Full Text News & Views Top HIGHLIGHTS Clin Pharmacol Ther 2013 95: 8-9; 10.1038/clpt.2013.224 Full Text ASCPT NEWS Clin Pharmacol Ther 2013 95: 10-14; 10.1038/clpt.2013.215 Full Text State of the Art Top Current Status of Targeted Therapy for Anaplastic Lymphoma Kinase–Rearranged Non–Small Cell Lung Cancer B Solomon, K D Wilner and A T Shaw Clin Pharmacol Ther 2013 95: 15-23; advance online publication, October 3, 2013; 10.1038/clpt.2013.200 Abstract | Full Text Treatment of BRAF-Mutant Melanoma: The Role of Vemurafenib and Other Therapies S Jang and M B Atkins Clin Pharmacol Ther 2013 95: 24-31; advance online publication, September 30, 2013; 10.1038/clpt.2013.197 Abstract | Full Text Novel Immunomodulatory Approaches for the Management of Multiple Sclerosis O H Kantarci, I Pirko and M Rodriguez Clin Pharmacol Ther 2013 95: 32-44; advance online publication, October 30, 2013; 10.1038/clpt.2013.196 Abstract | Full Text Topoisomerase 2β: A Promising Molecular Target for Primary Prevention of Anthracycline-Induced Cardiotoxicity P Vejpongsa and E T H Yeh Clin Pharmacol Ther 2013 95: 45-52; advance online publication, October 3, 2013; 10.1038/clpt.2013.201 Abstract | Full Text Antiobesity Pharmacotherapy: New Drugs and Emerging Targets G W Kim, J E Lin, E S Blomain and S A Waldman Clin Pharmacol Ther 2013 95: 53-66; advance online publication, October 8, 2013; 10.1038/clpt.2013.204 Abstract | Full Text Biomarker-Driven Therapeutic Management of Alzheimer’s Disease: Establishing the Foundations J Cummings and K Zhong Clin Pharmacol Ther 2013 95: 67-77; advance online publication, October 8, 2013; 10.1038/clpt.2013.205 Abstract | Full Text Novel Therapeutic Approaches for Hepatitis C J S Au and P J Pockros Clin Pharmacol Ther 2013 95: 78-88; advance online publication, October 14, 2013; 10.1038/clpt.2013.206 Abstract | Full Text Novel Therapeutics for the Treatment of Familial Mediterranean Fever: From Colchicine to Biologics I Grattagliano, L Bonfrate, V Ruggiero, G Scaccianoce, G Palasciano and P Portincasa Clin Pharmacol Ther 2013 95: 89-97; advance online publication, July 18, 2013; 10.1038/clpt.2013.148 Abstract | Full Text Prospects for Rapid Advances in the Development of New Medicines for Special Medical Needs C-P Milne Clin Pharmacol Ther 2013 95: 98-109; advance online publication, August 5, 2013; 10.1038/clpt.2013.155 Abstract | Full Text Corrigendum Top Corrigendum: Novel Therapeutics for the Treatment of Familial Mediterranean Fever: From Colchicine to Biologics Clin Pharmacol Ther 2013 95: 110; 10.1038/clpt.2013.213 Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Clinical Pharmacology & Therapeutics. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.